7 Patents
- US126126182026Nucleobase Editors Having Reduced Non-target Deamination and Assays for Characterizing Nucleobase Editors
Beam Therapeutics Inc.
0 cites - US126010092026Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic-acid Binding, Modifying, and Cleaving Agents
The General Hospital Corporation
0 cites - 0 cites
- 0 cites
- US122866412025Methods for Increasing Efficiency of Nuclease-induced Homology-directed Repair
The General Hospital Corporation
0 cites - US121338842024Methods of Substituting Pathogenic Amino Acids Using Programmable Base Editor Systems
Beam Therapeutics Inc.
0 cites - US117252282023Methods for Detecting Site-specific and Spurious Genomic Deamination Induced by Base Editing Technologies
The General Hospital Corporation
0 cites